Imperial Oil Limited Common Stock vs Natera Inc. Common Stock — how do they compare? Imperial Oil Limited Common Stock trades at $129.6 (market cap $62.22B), while Natera Inc. Common Stock trades at $394 (market cap $57.03B). The key difference: Imperial Oil Limited Common Stock and Natera Inc. Common Stock are close in size by market cap, and Imperial Oil Limited Common Stock pays a 1.9% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals.
| IMO | NTRA | |
|---|---|---|
Market Cap | $62.22B | $57.03B |
Volume | 560,544 | 1,131,157 |
Sector | Energy | Health |
52-Week High | $138.33 | $425.64 |
52-Week Low | $83.72 | $179.42 |
Enterprise Value | $63.13B | $56.18B |
Dividend Yield | 1.9% | — |
Typical Hold Time | — | 0 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Imperial Oil Limited is a Canadian integrated energy company that explores for and produces crude oil and natural gas, operates oil sands projects at Cold Lake, Kearl, and Syncrude, and refines and markets petroleum products under the Esso and Mobil brands. ExxonMobil Corporation holds a majority ownership stake in the company.
Read more on IMO →Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →